These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34675619)

  • 1. A Novel Pyroptosis-Related lncRNA Signature for Predicting the Prognosis of Skin Cutaneous Melanoma.
    Xie J; Li H; Chen L; Cao Y; Hu Y; Zhu Z; Wang M; Shi J
    Int J Gen Med; 2021; 14():6517-6527. PubMed ID: 34675619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a novel pyroptosis-related signature to predict prognosis in patients with cutaneous melanoma.
    Niu Z; Xu Y; Li Y; Chen Y; Han Y
    Math Biosci Eng; 2022 Jan; 19(1):688-706. PubMed ID: 34903008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma.
    Xue L; Wu P; Zhao X; Jin X; Wang J; Shi Y; Yang X; She Y; Li Y; Li C
    Int J Gen Med; 2021; 14():6463-6475. PubMed ID: 34675614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
    Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
    Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma.
    Wu Z; Chen L; Jin C; Xu J; Zhang X; Yao Y
    PeerJ; 2021; 9():e12304. PubMed ID: 34721986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new pyroptosis model can predict the immunotherapy response and immune microenvironment characteristics and prognosis of patients with cutaneous melanoma based on TCGA and GEO databases.
    Wang YY; Shi LY; Zhu ZT; Wang QJ
    Ann Transl Med; 2022 Mar; 10(6):353. PubMed ID: 35434038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma.
    Li AA; Zhang Y; Tong WL; Chen JW; Huang SH; Liu JM; Liu ZL
    Int J Gen Med; 2022; 15():6145-6163. PubMed ID: 35855761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis.
    Huang H; Shi Z; Li Y; Zhu G; Chen C; Zhang Z; Shi R; Su L; Cao P; Pan Z; Zhang H; Liu M; Liu H; Chen J
    Front Oncol; 2022; 12():850943. PubMed ID: 35311148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
    Zhang F; Deng Y; Wang D; Wang S
    Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
    Ping L; Zhang K; Ou X; Qiu X; Xiao X
    Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
    Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
    Front Oncol; 2022; 12():794034. PubMed ID: 35311105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer.
    Wu P; Shi J; Sun W; Zhang H
    Cancer Cell Int; 2021 Oct; 21(1):523. PubMed ID: 34627252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
    Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
    Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Pyroptosis-Related Subtypes with Distinct Immune Microenvironment Characteristics and a Novel Signature for Predicting Immunotherapy Response and Prognosis in Uveal Melanoma.
    Lei S; Li H
    Curr Eye Res; 2022 Jun; 47(6):930-943. PubMed ID: 35348009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
    Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
    Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel identified pyroptosis-related prognostic signature of colorectal cancer.
    Zheng C; Tan Z
    Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.